#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital disorder of glycosylation Small cell lung cancer limited stage Cerebellar ataxia Ewing's sarcoma Pseudomyxoma peritonei Adenocarcinoma gastric Hepatitis B General anaesthesia Oesophageal adenocarcinoma Dent's disease Myelin oligodendrocyte glycoprotein antibody-associated disease Hidradenitis Porphyria non-acute Bronchopulmonary dysplasia Fms-like tyrosine kinase 3 positive More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Diagnostics Pituitary-dependent Cushing’s syndrome – Diagnostics VEXAS syndrome Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Proteus syndrome – Trials in Disease Uterine leiomyosarcoma – Trials in Disease Short-bowel syndrome – Trials in Disease Testicular leiomyosarcoma – Diagnostics Splenic marginal zone lymphoma Leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Binimetinib SPY002 Pyrimethamine Misoprostol TAZAROTENE IMEROPRUBART Izokibep Mitapivat Thalidomide Rhh646 Copanlisib Dihydrochloride Levonorgestrel Nimorazole Lolium Perenne Thiamazole Anitocabtagene Autoleucel Varegacestat Ammonium Chloride VHB937 Enlicitide Chloride More therapies…

    Learn about Your Condition

    Hyperparathyroidism secondary Dyskinesia Hyperhidrosis Ependymoma malignant Normal pressure hydrocephalus Pulmonary hypertension Pre-eclampsia Antisynthetase syndrome Toxicity to various agents Emphysema Peritoneal abscess Labour pain Hyperinsulinism Ewing's sarcoma Neurotrophic keratopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University General Hospital Of Thessaloniki Ahepa

University General Hospital Of Thessaloniki Ahepa

1st St Kiriakidis Str, Thessaloniki, 546 36, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    • Lisaftoclax
    Belgium Bulgaria Czechia Finland France Germany +7

  • Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    Belgium France Greece Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Belantamab Mafodotin for Adults with Primary Immune Thrombocytopenia Previously Treated with Standard Medications

    Recruiting

    2 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Belantamab Mafodotin
    Greece

  • Study on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Pegaspargase
    • Rituximab
    Croatia Greece Hungary Slovenia

  • Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    Investigated Drugs:
    • Iptacopan Hydrochloride
    • Iptacopan
    Czechia France Germany Greece Italy The Netherlands +1

  • Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia Denmark Finland +12

  • Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ependymoma
    Investigated Drugs:
    • Sodium Valproate
    • Cisplatin
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland France +7

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Dactinomycin
    • Vinorelbine Tartrate
    • Ifosfamide
    Austria Belgium Czechia Denmark Finland France +10

  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Busulfan
    • Dinutuximab Beta
    • Irinotecan Hydrochloride Trihydrate
    Austria Belgium Czechia Denmark Finland France +13

  • Study on Early Clarithromycin Treatment to Prevent Sepsis in Patients with Community-Acquired Pneumonia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Clarithromycin
    Greece
Previous Page
1 2 3 4 5 6 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!